Press Release

Morgan Lewis Advises on Minerva Neurosciences IPO

July 02, 2014

NEW YORK, July 2, 2014: A team of Morgan Lewis lawyers advised Minerva Neurosciences Inc. on its initial public offering of nearly 5.5 million shares, which began trading July 1 on the NASDAQ Global Market under the ticker symbol “NERV.” Minerva is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. Jefferies LLC led the underwriters for the offering.

Advising Minerva were Business and Finance Practice partners David W. Pollak and Denis Segota, as well as Business and Finance associates Anna Tomczyk and JiWon Park.

For further information about the transaction, please see Minerva’s press release